Emergent BioSolutions EBS
NYSE EBS
$6.25 -0.11 (-1.73%)
As of: Oct 20, 2026 · 3:51 PM EDT

Emergent BioSolutions (EBS) EV to EBIT (2011 - 2026)

Updated

Emergent BioSolutions' (EBS) EV to EBIT stood at 4.44 in Q1 2026, up 1.4% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) EV to EBIT (2011 - 2026) Analysis & Trends

On a TTM basis, Emergent BioSolutions' EV to EBIT came in at -7.39 as of Mar 31, 2026; for FY2025, it came in at 4.38.

  • Across earlier years, EV to EBIT came in at 4.84 in FY2021 (-48.6%).
  • The Q1 2026 figure is the highest quarterly EV to EBIT since Q3 2022.
  • Per Business Quant, the preceding three quarters came in at 4.38 (Q4 2025), 1.85 (Q3 2025) and 0.71 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,148.30 Bn 1,116.89 Bn 19.71 Bn
2 Johnson & Johnson 624.42 Bn 542.95 Bn 17.26 Bn
3 AbbVie 509.35 Bn 482.46 Bn 12.70 Bn
4 Merck 366.08 Bn 320.46 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 236.09 Bn 191.49 Bn 7.24 Bn
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn
9 Pfizer 171.91 Bn 118.56 Bn 10.94 Bn
10 Emergent BioSolutions 322.50 Mn -428.40 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.44
Dec 31, 2025 4.38
Sep 30, 2025 1.85
Jun 30, 2025 0.71
Sep 30, 2022 4.69
Jun 30, 2022 6.90
Mar 31, 2022 6.38
Dec 31, 2021 4.84
Sep 30, 2021 7.31
Jun 30, 2021 7.01
Mar 31, 2021 8.24
Dec 31, 2020 9.54
Sep 30, 2020 19.97
Jun 30, 2020 14.89
Mar 31, 2020 21.90
Dec 31, 2019 22.97
Sep 30, 2019 53.86
Mar 31, 2019 34.21
Dec 31, 2018 32.55
Sep 30, 2018 22.51
API Access

Emergent BioSolutions EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=EBS&period=max&api_key=YOUR_API_KEY